Universiteit Leiden | Published October 15, 2015
Stichting TI Pharma en Roland Berger Strategy Consultants BV
71241000, 72227000, 72246000, 73200000, 73210000, 73220000, 79111000, 79410000
The Drug Disease Model Resources (DDMoRe: http://www.ddmore.eu) consortium is an Innovative Medicines Initiative (IMI: http://www.imi.europa.eu) project. IMI is a joint undertaking between the European Union and the European pharmaceutical industry association (EFPIA) and is the world's largest biomedical public-private partnership framework. IMI's overall goal is to invigorate the biopharmaceutical sector in Europe, initiating collaboration of the pharmaceutical industry and all stakeholder groups, i.e. academia; biopharmaceutical companies and SMEs; healthcare providers and clinical centres; regulators and patients' organisations.
DDMoRe needs a strategy to bring the output of the IMI, DDMoRe project into a sustainable platform, including a business plan, governance structure and IP strategy approved by all DDMoRe partners.